Is It Too Late to Buy Viking Therapeutics Stock?
Wednesday, 22 May 2024, 12:15
Why it isn't crazy to be worried about being too late
There are two distinct arguments for why it's already too late to buy Viking Therapeutics.
Common Knowledge Concerns
Investors worry that all positive aspects of Viking's prospects are already priced into the stock.
Competitive Landscape
Novo Nordisk and Eli Lilly's presence in the obesity market pose formidable challenges for Viking.
There's still plenty of meat on the bone
Future uncertainties like phase 3 trial results and FDA approval make it unlikely that all potential events are priced in. Even capturing a small market share could lead to substantial revenue growth for Viking.
Conclusion: No, it's not too late to invest in Viking Therapeutics stock, but be prepared for potential risks and a longer investment horizon.This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.